Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...

Statistical Software for Data Analysis and Clinical Trials

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhance Multistate Models With Clinically Meaningful Graphs.

CPT: pharmacometrics & systems pharmacology·2025

Same author

Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen.

Clinical pharmacology and therapeutics·2024

Same author

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.

Molecular cancer therapeutics·2019

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

Application of multistate modeling to clinical data analysis.

Joachim Grevel¹, Joshua Veasy², Blesson Chacko²

¹Joachim Grevel Consulting, Liebenau, Austria.

CPT: Pharmacometrics & Systems Pharmacology

|February 12, 2024

Summary

Multistate models offer valuable insights into drug development economics and clinical trials. This study introduces a minimal model to aid stakeholders in assessing treatment benefits and risks.

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: Jul 3, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

Pharmacometrics
Health Economics
Clinical Trial Simulation

Background:

Multistate models have a long history in analyzing expensive, long-term treatments.
These models are increasingly relevant for clinical drug development questions.
A broader introduction to their technical aspects and problem-solving capabilities is timely for the pharmacometrics community.

Purpose of the Study:

Introduce a minimal multistate model for pharmacometrics.
Address questions relevant to drug developers, regulatory agencies, and patients.
Demonstrate the model's utility in assessing treatment benefits and risks.

Main Methods:

Simulation of a clinical study with 1000 patients (1:1 placebo/active treatment).
A minimal multistate model with one initial, two transient, and two absorbing states.
Fully parameterized semi-Markov processes for unidirectional state transitions.
Exploration of parameter uncertainty and sample size effects on statistical inference.

Main Results:

The minimal model effectively addresses stakeholder questions, primarily through graphical displays.
Simulations highlight the impact of parameter uncertainty and sample size on inferential validity.
Programming code is provided for accessibility and application.

Conclusions:

The introduced minimal multistate model provides a robust framework for drug development analysis.
Stakeholders, including drug developers and regulators, are encouraged to reconsider current benefit-risk assessment methods.
The model facilitates a comprehensive evaluation of new treatments.